(Q35804757)

English

A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors

scientific article published on 27 January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors (English)

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

1 reference

based on heuristic

inferred from title

object named as

John J Powers

1

0 references

object named as

Satu Mustjoki

6

0 references

author name string

Jason A Dubovsky

2

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

P K Epling-Burnette

3

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Lynn Moscinski

4

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Ling Zhang

5

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Eduardo M Sotomayor

7

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Javier A Pinilla-Ibarz

8

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

publication date

27 January 2011

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

52

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

668-679

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

CD4 (+)CD25 (+)Foxp3 (+) regulatory T cells and hematologic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

The biological basis for immunotherapy in patients with chronic myelogenous leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

Network model of survival signaling in large granular lymphocyte leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

Expression and function of Tec, Itk, and Btk in lymphocytes: evidence for a unique role for Tec

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

Regulation of lymphoid homeostasis by interleukin-15

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

Role of interleukin 15 and interleukin 18 in inflammatory response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

Smart drugs: tyrosine kinase inhibitors in cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

Benign monoclonal expansion of CD8+ lymphocytes in HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

Specific human cellular immunity to bcr-abl oncogene-derived peptides.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4487410

11 July 2018

Profound inhibition of antigen-specific T-cell effector functions by dasatinib

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.550074

21 January 2018

Dasatinib suppresses in vitro natural killer cell cytotoxicity

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.550074

21 January 2018

The Src/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.550074

21 January 2018

Imatinib mesylate (STI-571) enhances antigen-presenting cell function and overcomes tumor-induced CD4+ T-cell tolerance

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.550074

21 January 2018

Increased IFN-gamma synthesis by T cells from patients on imatinib therapy for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.550074

21 January 2018

Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.550074

21 January 2018

Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.550074

21 January 2018

Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.550074

21 January 2018

Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.550074

21 January 2018

Pleural effusions in patients with chronic myeloid leukaemia treated with dasatinib may have an immune-mediated pathogenesis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.550074

21 January 2018

Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.550074

21 January 2018

Polyclonal proliferation of large granular lymphocytes during cytomegalovirus primary infection in a human immunodeficiency virus-infected patient receiving antiretroviral therapy

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.550074

21 January 2018

Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.550074

21 January 2018

Pleural Effusion in Patients With Chronic Myelogenous Leukemia Treated With Dasatinib After Imatinib Failure

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.550074

21 January 2018

Altered Bone and Mineral Metabolism in Patients Receiving Imatinib Mesylate

1 reference

https://pubmed.ncbi.nlm.nih.gov/21271862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21271862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/21271862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonal expanded TCR Vbeta T cells in patients with APL

1 reference

https://pubmed.ncbi.nlm.nih.gov/21271862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lung Abnormalities after Dasatinib Treatment for Chronic Myeloid Leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21271862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3109/10428194.2010.550074

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35804757&oldid=1523406453"